Amneal Pharmaceuticals Inc (AMRX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

400 CROSSING BOULEVARD BRIDGEWATER, NJ 08807

Amneal Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company specializes in developing, manufacturing, marketing, and distributing generic and biosimilar pharmaceutical products. Amneal Pharmaceuticals serves clients worldwide.

Data based on most recent fiscal year report
Market Cap1.591 Billion Shares Outstanding299.1 Million Avg Volume2.413 Million
1-Yr BETA vs S&P TR2.348 Current Ratio2.32 Quick Ratio1.5

Are you looking for this stock instead?

View SEC Filings from AMRX instead.

View recent insider trading info

Funds Holding AMRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AMRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

47.7 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BRANNING TODD P. SVP AND CFO

  • Officer
12,785 2020-01-22 2

VERGIS JANET S.

  • Director
2,014 2020-01-10 1

BUCHEN DAVID A SVP, CHIEF LEGAL OFFICER

  • Officer
20,426 2020-01-03 1

MEISTER PAUL M

9,021 2020-01-02 2

MANZANO STEPHEN SVP, GENERAL COUNSEL

  • Officer
0 2020-01-02 1

KIELY JOHN

  • Director
0 2019-12-31 2

GEORGE JEFFREY P.

  • Director
0 2019-12-14 2

YANAI SHLOMO

  • Director
0 2019-12-14 2

FOSUN INTERNATIONAL LTD

  • 10% Owner
23,819,500 2019-12-06 2

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • FORMER DIRECTOR AND 10% OWNERFORMER DIRECTOR AND 10% OWNERFORMER DIRECTOR AND 10% OWNER
3,740,931 2019-11-20 1

BHADAURIA PRADEEP SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-11-13 4

TODISCO JOSEPH SVP, SPECIALTY COMMERCIAL

  • Officer
0 2019-11-13 4

BOYER ANDREW S EXEC VP, COMM OPTNS

  • Officer
0 2019-11-13 4

SHAH NIKITA SVP, CHIEF HR OFFICER

  • Officer
0 2019-11-13 2

PATEL GAUTAM

  • Director
  • 10% Owner
17,503,443 2019-11-11 2

BUCHI J KEVIN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2019-10-23 1

NARK TED C

  • Director
56,107 2019-08-28 2

BISARO PAUL EXECUTIVE CHAIRMAN

  • Officer
  • Director
29,454 2019-05-07 1

STEWART ROBERT A PRESIDENT AND CEO

  • Officer
  • Director
78,668 2019-05-07 1

PATEL CHINTU

  • Director
  • 10% Owner
6,107 2019-05-06 1

RAMA DHARMENDRA

  • Director
6,107 2019-05-06 1

BURR ROBERT L

  • Director
102,639 2019-05-06 1

TERRERI PETER R

  • Director
76,299 2019-05-06 1

GREENE JEAN SELDEN

  • Director
6,107 2019-05-06 1

PATEL CHIRAG K.

  • Director
  • 10% Owner
6,107 2019-05-06 1

ALVA EMILY PETERSON

  • Director
6,107 2019-05-06 1

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

BRANNING TODD P. - Officer SVP AND CFO

2020-01-22 M 20,096 d 60,290 12,785.00 direct

BRANNING TODD P. - Officer SVP AND CFO

2020-01-22 F 7,311 $5.13 d 12,785 12,785.00 direct

BRANNING TODD P. - Officer SVP AND CFO

2020-01-22 M 20,096 a 20,096 12,785.00 direct

BUCHEN DAVID A - Officer SVP, CHIEF LEGAL OFFICER

2020-01-03 M 27,614 d 82,843 20,426.00 direct

BUCHEN DAVID A - Officer SVP, CHIEF LEGAL OFFICER

2020-01-03 F 8,188 $4.72 d 20,426 20,426.00 direct

BUCHEN DAVID A - Officer SVP, CHIEF LEGAL OFFICER

2020-01-03 M 27,614 a 28,614 20,426.00 direct

YANAI SHLOMO - Director

2019-12-14 A 28,506 a 28,506 0.00 direct

KIELY JOHN - Director

2019-12-14 A 7,522 a 7,522 0.00 direct

GEORGE JEFFREY P. - Director

2019-12-14 A 7,522 a 7,522 0.00 direct

KIELY JOHN - Director

2019-12-14 A 28,506 a 28,506 0.00 direct

YANAI SHLOMO - Director

2019-12-14 A 7,522 a 7,522 0.00 direct

GEORGE JEFFREY P. - Director

2019-12-14 A 28,506 a 28,506 0.00 direct

**EXPERIMENTAL** Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin
Point72 Asset Management, L.P. AMNEAL PHARMACEUTICALS, INC. 0.58% 2018-06-13 GERMANY

Short Position History

Holder Net Short Position Position Date Origin
Point72 Asset Management, L.P. AMNEAL PHARMACEUTICALS, INC. 0.63% 2018-05-25 GERMANY
Point72 Asset Management, L.P. AMNEAL PHARMACEUTICALS, INC. 0.54% 2018-05-23 GERMANY
Click here to report any possible errors with this stock listing.

Elevate your investments